Heska Corporation (NASDAQ:HSKA) is scheduled to announce its earnings results before the market opens on Monday, July 31st. Analysts expect the company to announce earnings of $0.37 per share for the quarter.
Heska Corporation (NASDAQ:HSKA) last issued its earnings results on Tuesday, May 2nd. The medical research company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.24 by $0.37. The company had revenue of $30.38 million during the quarter, compared to analysts’ expectations of $33.31 million. Heska Corporation had a net margin of 10.45% and a return on equity of 15.20%. The business’s revenue was up 11.9% compared to the same quarter last year. On average, analysts expect Heska Corporation to post $1.91 EPS for the current fiscal year and $2.03 EPS for the next fiscal year.
Shares of Heska Corporation (NASDAQ:HSKA) opened at 106.80 on Friday. Heska Corporation has a 12 month low of $42.37 and a 12 month high of $110.25. The company has a market cap of $759.99 million, a PE ratio of 57.20 and a beta of 0.81. The firm’s 50 day moving average is $99.82 and its 200 day moving average is $94.30.
TRADEMARK VIOLATION NOTICE: This piece was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/30/heska-corporation-hska-set-to-announce-quarterly-earnings-on-monday.html.
In other Heska Corporation news, Director Sharon J. Larson purchased 1,000 shares of the business’s stock in a transaction dated Thursday, May 4th. The shares were bought at an average price of $90.00 per share, for a total transaction of $90,000.00. Following the completion of the acquisition, the director now owns 3,294 shares in the company, valued at $296,460. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael J. Mcginley sold 11,189 shares of Heska Corporation stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $98.53, for a total transaction of $1,102,452.17. Following the transaction, the insider now owns 111,877 shares in the company, valued at approximately $11,023,240.81. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,265 shares of company stock worth $2,983,439. 14.70% of the stock is owned by company insiders.
A number of equities analysts have recently commented on HSKA shares. Aegis started coverage on shares of Heska Corporation in a report on Thursday, June 1st. They set a “buy” rating and a $114.50 price target on the stock. Zacks Investment Research upgraded shares of Heska Corporation from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a report on Thursday, May 4th. BidaskClub lowered shares of Heska Corporation from a “buy” rating to a “hold” rating in a report on Sunday, July 16th. Finally, B. Riley reiterated a “neutral” rating and set a $85.00 price target on shares of Heska Corporation in a report on Friday. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $95.50.
Heska Corporation Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.